Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Image Case Report: Milk of Urate Bulla

Samantha C. Shapiro, MD  |  Issue: October 2022  |  October 10, 2022

FIGURE 1: Milk of urate bulla. (Click to enlarge.)

A 60-year-old Black woman with a history of stage 3 chronic kidney disease, type 2 diabetes and hypertension presented with a 12-month history of asymmetric polyarthritis of the wrists, metacarpophalangeal (MCP), proximal interphalangeal (PIP), metatarsophalangeal (MTP) and knee joints.

The review of systems was unremarkable. She denied oral ulcers, rashes, alopecia, or a history of pleural or pericardial effusions. She denied a history of psoriasis, dactylitis, inflammatory back pain, uveitis, abdominal pain, melena or hematochezia. There was no history of podagra, tophi or acute monoarthritis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Laboratory studies were notable only for a positive anti-nuclear antibody at a titer of 1:80 with a homogenous pattern, and an elevated serum urate level of 9.5 mg/dL. She had chronic creatinine elevation, normocytic anemia and proteinuria attributed to diabetic nephropathy. Extractable nuclear antigens, complement levels, rheumatoid factor and anti-cyclic citrullinated peptide were negative.

In October 2018, treatment with adalimumab and prednisone was initiated with improvement of synovitis, but the patient’s disease flared upon tapering of the glucocorticoids. In July 2019, she presented to the clinic in tears, with acute monoarthritis of the right knee. She was unable to bear weight.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Arthrocentesis revealed inflammatory synovial fluid with 40,000 white blood cells/µL (neutrophil predominant). Gram stain, bacterial cultures and crystals were negative. She responded positively to glucocorticoids. Over the next year, her disease remained active in the hands, feet and knees, with minimal response to etanercept, tofacitinib or tocilizumab.

In October 2020, the patient returned to the clinic with hard, sub-centimeter, white lesions on her finger pads. A warm effusion of her left first MTP joint and a white blister on her left second toe were also noted on examination (see Figure 1). There was no sclerodactyly, Raynaud’s phenomenon or muscle weakness. Nailfold capillaries, muscle strength and creatinine kinase levels were normal.

Aspiration of the first MTP joint and blister yielded 5 cc of chalky white fluid (see Figure 2). Polarized light microscopy revealed negatively birefringent crystals consistent with monosodium urate. Her serum urate level was 9.7 mg/dL. Repeat radiographs of both hands and feet showed interval erosive changes in both midfeet, consistent with gouty arthropathy.

FIGURE 2: Milk of urate aspirated from the first MTP joint and milk of urate bulla. (Click to enlarge.)

Allopurinol was initiated and titrated to a goal serum urate of less than 6.0 mg/dL, per the 2020 ACR Guideline for the Management of Gout.1 Five milligrams of prednisone by mouth daily was continued as flare prophylaxis.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:case reportGoutmilk of urate bulla

Related Articles

    Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4

    October 14, 2019

    Three clinical experts on gout offer their insights into common management errors, clinical pearls, new safety data from the FDA and the role of biologic therapies in the management of gout.

    Difficult Gout

    July 1, 2007

    “Grandpapa’s Torments” was the Rodnan Commemorative Gout Print featured at the 2005 ACR/ARHP Annual Scientific Meeting.

    Lost and found

    Understanding the Role of Uric Acid in Gout

    September 6, 2022

    From the first substantial argument in the 19th century that uric acid played a role in gout, it took about 100 years for the medical community to accept its role in triggering acute inflammatory gout attacks. Two papers, both published in 1962, helped demonstrate the link between uric acid and acute gout attacks, quickly opening…

    Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021’

    November 10, 2021

    Dr. Lisa Stamp helps filter the noise to get to the key insights from the research abstracts on gout presented at ACR Convergence 2021.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences